Defining reliable disability outcomes in multiple sclerosis

- Kalincik, Thomas, Cutter, Gary, Prat, Alexandre, Lugaresi, Alessandra, Grand'Maison, Francois, Grammond, Pierre, Hupperts, Raymond, Oreja-Guevara, Celia, Boz, Cavit, Pucci, Eugenio, Bergamaschi, Roberto, Lechner-Scott, Jeannette, Spelman, Tim, Alroughani, Raed, Van Pesch, Vincent, Iuliano, Gerardo, Fernandez-Bolaños, Ricardo, Ramo, Cristina, Terzi, Murat, Slee, Mark, Spitaleri, Daniele, Verheul, Freek, Cristiano, Edgardo, Jokubaitis, Vilija, Sánchez-Menoyo, José Luis, Fiol, Marcela, Gray, Orla, Cabrera-Gomez, Jose Antonio, Barnett, Michael, Butzkueven, Helmut, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Girard, Marc, Duquette, Pierre

Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature

- Grand, M. M., O'Brien, P. C.

Acute stroke imaging research roadmap II

- Wintermark, Max, Albers, Gregory W., Lev, Michael H., Liebskind, David S., Luby, Marie, Muir, Keith W., Parsons, Mark W., von Kummer, Rüdiger, Wardlaw, Joanna M., Wu, Ona, Yoo, Albert J., Alexandrov, Andrei V., Broderick, Joseph P., Alger, Jeffry R., Aviv , Richard I., Bammer, Roland, Baron, Jean-Claude, Calamante, Fernando, Campbell, Bruce C. V., Carpenter, Trevor C., Christensen, Søren, Copen, William A., Derdeyn , Colin P., Demchuck, Andrew M., Haley Jr, E. Clarke, Khatri, Pooja, Kudo, Kohsuke, Lansberg, Maarten G., Latour, Lawrence L., Lee, Ting-Yim, Leigh, Richard, Lin, Weili, Lyden, Patrick, Mair, Grant, Fiebach, Jochen B., Menon, Bijoy K., Michel, Patrik, Mikulik, Robert, Nogueira, Raul G., Østergaard, Leif, Pedraza, Salvador, Riedel, Christian H., Rowley, Howard A., Sanelli, Pina C., Sasaki, Makato, Fiehler, Jens, Saver, Jeffrey L., Schaefer, Pamela W., Schellinger, Peter D., Tsivgoulis, Georgios, Wechsler, Lawrence R., White, Philip M., Zaharchuk, Greg, Zaidat, Osama O., Davis, Stephen M., Donnan, Geoffrey, Grotta, James C., Furlan, Anthony J., Hacke, Werner, Kang, Dong-Wha, Kidwell, Chelsea, Thijs, Vincent N., Thomalla, Götz, Warach, Steven J., Houser, Gary, Jovin, Tudor G., Lees, Kennedy R.

Results from the partnership for advancement in neuromodulation registry: a 24-month follow-up

- Deer, Timothy, Skaribas, Ioannis, McJunkin, Tory, Nelson, Christopher, Salmon, John, Darnule, Amit, Braswell, John, Russo, Marc, Fernando Gomezese, Omar

Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial

- Kearvell, Rachel, Haworth, Annette, Denham, James W., Ebert, Martin A., Murray, Judy, Hooton, Ben, Richardson, Sharon, Joseph, David J., Lamb, David, Spry, Nigel A., Duchesne, Gillian

Role of imaging in current acute ischemic stroke workflow for endovascular therapy

- Menon, Bijoy K., Campbell, Bruce C.V., Levi, Christopher, Goyal, Mayank

Mannitol and outcome in intracerebral hemorrhage: propensity score and multivariable intensive blood pressure reduction in acute cerebral hemorrhage Trial 2 results

- Wang, Xia, Arima, Hisatomi, Heeley, Emma, Delcourt, Candice, Lindley, Richard I., Parsons, Mark, Chalmers, John, Anderson, Craig S., Yang, Jie, Zhang, Shihong, Wu, Guojun, Woodward, Mark, Muñoz-Venturelli, Paula, Lavados, Pablo M., Stapf, Christian, Robinson, Thompson

Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field

- Sanson-Fisher, Rob, Brand, Matthew, Shakeshaft, Anthony, Haber, Paul, Day, Carolyn, Conigrave, Katherine, Mattick, Richard, Lintzeris, Nicholas, Teesson, Maree

Improving outcomes after stroke clinical pilot trial protocol

- Hackett, M. L., Carter, G., Crimmins, D., Clarke, T., Maddock, K., Sturm, J. W.

ImProving outcomes after STroke (POST): results from the randomized clinical pilot trial

- Hackett, Maree L., Carter, Greg, Crimmins, Denis, Clarke, Tracy, Arblaster, Lucy, Billot, Laurent, Mysore, Jayanthi, Sturm, Jonathon

Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics

- Talley, Nicholas J., Locke III, G. Richard, El-Serag, Hashem B., Abraham, Bincy P., Moayyedi, Paul, Zinsmeister, Alan R., Herrick, Linda M., Silvernail, Vickie M., Prather, Charlene M., Lacy, Brian E., DiBaise, John K., Howden, Colin W., Brenner, Darren M., Bouras, Ernest P.

Dyspepsia in the community: value of a community-based mailed survey to identify potential participants for a randomized clinical trial

- Herrick, Linda M., Locke III, Giles Richard, Schleck, Cathy D., Zinsmeister, Alan R., Treder, Vickie, Talley, Nicholas J.

The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2)

- Delcourt, C., Huang, Y., Neal, B., Chalmers, J., Anderson, C., Wang, J., Heeley, E., Lindley, R., Stapf, C., Tzourio, C., Arima, H., Parsons, M., Sun, J.

A programme for reducing smoking in pre-operative surgical patients: randomised controlled trial

- Wolfenden, Luke, Wiggers, John, Knight, Jennifer, Campbell, Elizabeth, Rissel, C., Kerridge, R., Spigelman, Allan David, Moore, K.

Enrolment of patients to clinical trials in haematological cancer in New South Wales: current status, perceived barriers and opportunities for improvement

- Murray, P., Kerridge, I., Tiley, C., Catanzariti, A., Welberry, H., Lean, C., Sinclair, S., Bishop, J., Bradstock, K.

Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00

- Colleoni, Marco, Gray, Kathryb P., Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio

Combination of vancomycin and β-lactam therapy for methicillin-resistant staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial

- Davis, Joshua S., Majumdar, S, Ralph, A, Baird, R, Gordon, C, Jeremiah, C, Leung, G, Brischetto, A, Crowe, A, Dakh, F, Whykes, K, Kirkwood, M, Owen, S, Menon, M, Somerville, L, Subedi, S, O'Sullivan, M, Liu, E, Zhou, F, Robinson, O, Coombs, G, Ferguson, P, Pollet, S, Van Hal, S, Davis, R, Sud, Archana, Kirby, Adrienne, Tong, Steven Y. C., O'Sullivan, Matthew V. N., Robinson, James O., Ferguson, Patricia E., Foo, Hong, van Hal, Sebastiaan J., Ralph, Anna P., Howden, Benjamin P., Binks, Paula M.

Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: are the results reflected in observed toxicity rates?

- Ebert, Martin A., Bulsara, Max, Haworth, Annette, Kearvell, Rachel, Richardson, Sharon, Kennedy, Angel, Spry, Nigel A., Bydder, Sean A., Joseph, David J., Denham, James W.

Gene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trials

- Deakin, Claire T., Alexander, Ian E., Hooker, Cliff A., Kerridge, Ian H.

L-Theanine and caffeine improve target-specific attention to visual stimuli by decreasing mind wandering: a human functional magnetic resonance imaging study

- Kahathuduwa, Chanaka N., Dhanasekara, Chathurika S., Chin, Shao-Hua, Davis, Tyler, Weerasinghe, Vajira S., Dassanayake, Tharaka L., Binks, Martin